{"id":152231,"date":"2017-10-16T11:07:02","date_gmt":"2017-10-16T11:07:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=152231"},"modified":"2017-10-16T11:07:02","modified_gmt":"2017-10-16T11:07:02","slug":"macrolide-antibiotics-market-by-indication-drugs-administration-analysis-and-forecasts-to-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/macrolide-antibiotics-market-by-indication-drugs-administration-analysis-and-forecasts-to-2023_152231.html","title":{"rendered":"Macrolide Antibiotics Market by Indication, Drugs, Administration, Analysis and Forecasts To 2023"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Market Research Future”<\/div>\n<\/div>\n<\/div>\n
The Global Macrolide Antibiotics Market is segmented on the basis of drugs which includes azithromycin, clarithromycin, erythromycin, fidaxomicin, and telithromycin.<\/div>\n

Pune, India, October 16, 2017\/MRFR Press Release\/- Market Research Future published a research report on “<\/span><\/span>Macrolide Antibiotics Market<\/span><\/span><\/strong>” – <\/span><\/span>Market Analysis, Trends , Scope, Stake, Progress and Forecast to 2023.<\/span><\/span><\/p>\n

The Global <\/span><\/span>Macrolide Antibiotics Market<\/span><\/span><\/strong><\/a>is expected to grow at a CAGR of 12.5% during the forecast period from 2017-2023.<\/span><\/span><\/p>\n

Macrolides are a class of antibiotics derived from Saccharopolyspora erythraea. They inhibit protein synthesis in bacteria by binding to the 50S ribosomal element and effective against gram positive bacteria and intracellular pathogens such as Legionella, Mycoplasma, and Chlamydia. It primarily act as a bacteriostatic agent against many strains of Corynebacteria, Listeria, Moxicella, Streptococci, Neisseria meningitides, Staphylococci, Clostridia, and Haemophilus sp.<\/span><\/span><\/p>\n

The market of macrolide antibiotics exhibits a significant growth across the globe owing to the increasing prevalence of skin infections and growing demand for drugs against bacterial skin infections.<\/span><\/span><\/p>\n

Major concerns involved in the use of macrolide antibiotics are GI disturbances and inhibition of hepatic metabolism. According to a study published in the Journal of the American College of Cardiology, macrolide antibiotics may increase the risk of sudden cardiac death, ventricular tachyarrhythmias, and cardiovascular death in patients, which may hinder the growth of the market over the review period.<\/span><\/span><\/p>\n

Get Sample Copy @ <\/span><\/span><\/strong>https:\/\/www.marketresearchfuture.com\/sample_request\/4342<\/span><\/span><\/a> .<\/span><\/span><\/p>\n

Regional Analysis of the Global Macrolide Antibiotics Market:<\/span><\/span><\/strong><\/p>\n

The American region accounted for the largest share of the global market due to increasing prevalence of skin infections, and presence of prominent market players. The prevalence of bacterial skin infection increasing in the US from the last few years. Also, the number of visits to the emergency department has increased. Furthermore, increasing dose of antibiotics in number of out-patient settings in the U.S, which will drive the growth of the market over the forecast period.<\/span><\/span><\/p>\n

Europe is the second largest market that holds a noticeable share of the global macrolide antibiotics market. In France, prevalence of symptomatic cat-scratch disease has been increasing from the last few years.<\/span><\/span><\/p>\n

In Asia Pacific, prevalence of skin disease is found to be increasing in Japan. Rising prevalence of skin diseases, and growing awareness about the use of macrolides for the treatment of uncomplicated skin infections drives the market in Asia Pacific.<\/span><\/span><\/p>\n

The Middle East and Africa show steady growth in the macrolide antibiotics market.<\/span><\/span><\/p>\n

The Major <\/span><\/span>Key players profiled in the report are Merck Sharp & Dohme Corp (U.S.), Pfizer Inc. (U.S.), Neo Química (Brazil), Macrolide Pharmaceuticals (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Fresenius Kabi USA (U.S.),  Sandoz International GmbH (Germany), Gland Pharma Limited (India), Mylan N.V. (U.S.),and WOCKHARDT (U.S.).<\/span><\/span><\/p>\n

Major TOC for Macrolide Antibiotics Market:<\/span><\/span><\/strong><\/p>\n

1 Report Prologue <\/span><\/span><\/strong><\/p>\n

2 Market Introduction <\/span><\/strong><\/span><\/span><\/strong><\/p>\n

2.1 Introduction<\/p>\n

2.2 Scope of Study<\/p>\n

2.3 Research Objective<\/p>\n

2.4 Assumptions & Limitations<\/p>\n

2.4.1 Assumptions<\/p>\n

2.4.2 Limitations<\/span><\/span><\/p>\n

Get Discount @<\/span><\/span><\/strong> https:\/\/www.marketresearchfuture.com\/check-discount\/4342<\/span><\/span><\/a> .<\/span><\/span><\/p>\n

3 Research Methodology <\/span><\/span><\/strong><\/p>\n

3.1 Research Process<\/p>\n

3.2 Primary Research<\/p>\n

3.3 Secondary Research<\/p>\n

4 Market Dynamics <\/span><\/strong><\/p>\n

4.1 Drivers<\/p>\n

4.2 Restraints <\/span><\/span><\/p>\n

….Continued<\/span><\/span><\/strong><\/p>\n

About US:<\/span><\/span><\/strong><\/p>\n

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.<\/span><\/span><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Market Research Future
Contact Person:<\/strong> Akash Anand
Email:<\/strong> akash.anand@marketresearchfuture.com
Phone:<\/strong> +1 646 845 9312
Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/www.marketresearchfuture.com\/reports\/macrolide-antibiotics-market-4342<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Market Research Future” The Global Macrolide Antibiotics Market is segmented on the basis of drugs which includes azithromycin, clarithromycin, erythromycin, fidaxomicin, and telithromycin. Pune, India, October 16, 2017\/MRFR Press Release\/- Market Research Future published a research report on “Macrolide Antibiotics … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-152231","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/152231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=152231"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/152231\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=152231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=152231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=152231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}